BIOLYTE’s horizons are brightening up. The “medical-grade” hydration beverage maker announced a packaging refresh this Spring – the third in the brand’s history and its first look update since 2019 – as it seeks to supercharge volume sales and grow its business in the Midwest. Founder and CEO Jesslyn Rollins said her “Spidey senses” were tingling over the brand’s need of something new to drive momentum before a rebrand, but after a call with a QuikTrip buyer she was told that BIOLYTE lacked the premium look and feel of a brand at its price point. That call put the rest into motion. “We wanted to make it look like this drink could be seen on a football field, on a basketball court, in your home and in a hospital,” Rollins said. “And so we think that this package really covers all of the bases of our consumers.” It’s one part of a broader strategy to regain momentum in retail. According to Circana, BIOLYTE’s U.S. retail and MULO sales were down 19.4% to $32.2 million in 2024. But the brand has been doing well online, up over 50% to drive total company growth of around 30% YoY. The moves to charge retail also includes promoting COO Trey Sinclair to the joint role of President and COO and an introduction of its powder stick line to drug stores to over 6,000 CVS and Walgreens this summer. “We are being very methodical and strategic, and we’re having to turn retailers down, because we are not in a position where a retailer can just be a marketing expense for us,” Rollins said. Insiders can read the full story BIOLYTE’s new strategy on BevNET. |